Karol Bagh | IAS GS Foundation Course | 29 May, 6 PM Call Us
This just in:

State PCS

Daily Updates

Rapid Fire

CMFRI Commercializes Seaweed-Based Nutraceuticals

  • 22 Dec 2023
  • 1 min read

The Indian Council of Agricultural Research(ICAR)- Central Marine Fisheries Research Institute (CMFRI) has successfully commercialized two seaweed-based nutraceutical products, CadalminTM Immunalgin extract (CadalminTM IMe) and CadalminTM Antihypercholesterolemic extract (CadalminTM ACe).

  • These products, developed with eco-friendly 'green' technology, aim to boost anti-viral immunity and combat high cholesterol or dyslipidemia (imbalance of cholesterol).
  • The product is positioned as a potential remedy against post-Covid complications, exhibiting antiviral properties against the delta variant of SARS CoV-2.
  • Seaweeds, primitive marine algae, lacking roots, stems, and leaves, play a vital role in marine ecosystems.
    • Seaweeds offer nutritional benefits and medicinal properties, containing anti-inflammatory and anti-microbial agents with potential cancer-fighting effects.


SMS Alerts
Share Page